Navigation Links
Octapharma Group and Fresenius Kabi Enter Into an Exclusive License, Development and Supply Agreement for a HESylated Recombinant Protein
Date:10/28/2009

BAD HOMBURG, Germany and LACHEN, Switzerland, Oct. 28 /PRNewswire/ -- Octapharma Group and Fresenius Kabi have signed a License, Development and Supply Agreement regarding the use of Fresenius Kabi's HESylation® Technology to develop a HESylated recombinant protein.

Under the agreement, Fresenius Kabi will license its proprietary HESylation® Technology to Octapharma. This technology platform is based on hydroxyethyl starch ("HES") which will be combined with a recombinant protein from Octapharma's human cell-line platform -- this combination is intended to generate a therapeutic protein with a superior product profile.

Fresenius Kabi will seek to adapt and optimize the protein modification by its HESylation® Technology and will afterwards be responsible for providing the appropriate HES derivative to Octapharma. Under the agreement, Octapharma will oversee the further development and commercialization. Fresenius Kabi will receive up-front and milestone payments, research funding and royalties on sales for licensing of the HESylation® Technology.

Octapharma's human cell-line platform

Octapharma's core business is the development, production and sale of high quality human protein therapies from both human plasma and human cell lines. Over the last twelve years, Octapharma has successfully established the human HEK293F cell-line platform for the expression of a variety of recombinant therapeutic proteins on a commercial scale.

An investigational new drug application for Octapharma's human cell-line derived recombinant FVIII was filed in the U.S. in May 2008. Using a human cell-line expression system instead of e.g. hamster cell-lines is expected to result in possible advantages like improved protein functions, increased tolerability and the opportunity for reduced immunogenicity.

HESylation® Technology

HESylation® Technology is based on th
'/>"/>

SOURCE Octapharma
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Plasma Products Safe Despite Swine Influenza Outbreak, Assures International Biopharmaceutical Company Octapharma
2. Octapharma Accepting Applications for Research Grants on Immunotherapy, Coagulation Disorders and Critical Care
3. Octapharma Targeting the Major Risk of Hemophilia Treatment - FVIII Antibodies
4. Baxter and The Alzheimers Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimers Disease
5. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
6. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
7. President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its Stop Neglected Tropical Disease Campaign
8. Ethics Group Asks USAID Inspector General to Investigate Legality of Grants to Soros Groups
9. Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKline
10. Coley Pharmaceutical Group Diversifies Pipeline with First-in-Class TLR Antagonist for the Treatment of Systemic Lupus Erythematosus
11. Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... , April 28, 2015 Konica ... achieved record sales growth for fiscal year ended ... digital radiography family of Primary Imaging Solutions.  The ... fueled company growth to double digit sales figures ... solutions includes the AeroDR XE, a wireless flat ...
(Date:4/28/2015)... 28, 2015  nUro, Inc. (the "Company") announced ... invest in Rosellini Scientific Benelux, SPRL. This marks the ... equity injections and one acquisition). nUro, Inc. plans to ... rapid prototyping labs in Wallonia and in conjunction ... investment comes in conjunction with notice of an ...
(Date:4/28/2015)... BIRMINGHAM, Ala. , April 28, 2015 /PRNewswire/ ... solution company for quickly and accurately capturing complete ... introduces the rebranding of its software platform to ... learns and simplifies what surgeons need to successfully ... unreasonable and unacceptable burden on surgeons to micro-dictate ...
Breaking Medicine Technology:Konica Minolta Sets Record Digital Radiography Sales 2nUro, Inc. Invests in Wallonia-Based Medtech Company 2nUro, Inc. Invests in Wallonia-Based Medtech Company 3nUro, Inc. Invests in Wallonia-Based Medtech Company 4Vincari introduces Lightspeed Valet, a web and mobile software solution for delivering ICD-10 surgical documentation at the point-of-care with extreme speed and accuracy 2
... 3, 2011 Clinicians may soon have a new tool ... – one of the most common sexually transmitted infections in ... and Company) (NYSE: BDX ), announced today that ... clearance for the first fully automated molecular tests to diagnose ...
... 2011 See video from Endo Pharmaceuticals at: ... The FDA has approved Fortesta™ (testosterone) ... low testosterone or "Low T," a condition that ... States. Available content includes an audio news release, ...
Cached Medicine Technology:New Amplified Molecular Tests Promise to Help Improve Diagnosis and Treatment of Herpes Patients 2
(Date:4/28/2015)... California (PRWEB) April 28, 2015 ... Skin Concierge have developed a new, online acne ... for acne sufferers using their specialized acne mapping ... anywhere in the state of California with internet ... need to travel to a physical office. The ...
(Date:4/28/2015)... FL (PRWEB) April 28, 2015 Two ... System were named to Becker's Hospital Review’s list ... . Peter Pronovost, M.D., Ph.D. , director of ... and senior vice president for patient safety and ... M.D., M.H.C.M. , vice president of medical affairs and ...
(Date:4/28/2015)... 28, 2015 The popular all-natural supplement ... for their newly launched L-Style Revolution Program™, and collectively ... counting in just two short months. The customized ... exercise plan for men and women of all health ... loss and weight maintenance goals faster than traditional methods. ...
(Date:4/28/2015)... April 28, 2015 An Allegheny ... A. Jobe, MD, FACS , has launched the first ... with extracellular matrix (ECM) can help patients who are ... esophageal cancer. , ECM is a complex mixture of ... and migration and signals that guide cell behavior. ECM, ...
(Date:4/28/2015)... 28, 2015 As the Muscular ... healthcare services programs, the organization has hired Scientific ... to MDA from Fidelity Biosciences Research Initiative where, ... projects in neurodegenerative diseases such as Alzheimer’s Disease, ... her time at Fidelity, she was a junior ...
Breaking Medicine News(10 mins):Health News:New Online Acne Treatment Service for California 2Health News:Johns Hopkins Medicine and All Children’s Hospital Leaders Recognized as Top Experts in Patient Safety 2Health News:Johns Hopkins Medicine and All Children’s Hospital Leaders Recognized as Top Experts in Patient Safety 3Health News:Johns Hopkins Medicine and All Children’s Hospital Leaders Recognized as Top Experts in Patient Safety 4Health News:Sports Nutrition Supplement Brand, Liporidex, Is Making History With Its New L-Style Revolution Diet & Exercise Program Reaching Over 10,000 Pounds Lost In Two Months 2Health News:Sports Nutrition Supplement Brand, Liporidex, Is Making History With Its New L-Style Revolution Diet & Exercise Program Reaching Over 10,000 Pounds Lost In Two Months 3Health News:Allegheny Health Network Launches First U.S. Clinical Trial of Extracellular Matrix as Replacement for Pre-Cancerous Tissue 2Health News:Allegheny Health Network Launches First U.S. Clinical Trial of Extracellular Matrix as Replacement for Pre-Cancerous Tissue 3Health News:MDA Adds Neurological Disease Expert to Research Team 2Health News:MDA Adds Neurological Disease Expert to Research Team 3
... of the National Academy of Science, scientists have found ... work of an enzyme that insects’ immune systems use ... so-called gene-for-gene interactions are thought to be common in ... a pathogen targeting a single gene in an animal ...
... common, affecting one in 70 schoolchildren, available data says. The ... ,A joint team of scientists from the King's ... are taking up a seven-year study and hope to rope ... babies being studied are between four and 11 months and ...
... is no dearth of "anti-aging" products and surgeries// in the ... go for them not just to enhance their looks, but ... enough in the market place, many observers point out. ... The toxin blocks the transmission of acetylcholine from the nerves ...
... in the US. A Defence Department panel has warned ... serious challenge on two fronts. ,One, soldiers are ... at the current level of staffing and funds, the military ... necessary statement. ,In a damning revelation, the ...
... who lost their lives to work- related cancers and heart ... new labor laws state that they no// longer need to ... compensation due the dead worker’s family. , ... that will be presumed to have been work-related when contracted ...
... on Tuesday launched a campaign to encourage Hispanics to ... rate for U.S. Hispanics increased from 11.6% in 1991 ... to be obese and two times more likely to ... AP/Star reports. ,LNC's campaign features a ...
Cached Medicine News:Health News:Scientists Discover Rare ‘gene-for-gene’ Interaction That Helps Bacteria Kill Their Ho 2Health News:UK Scientists to Undertake Seven Year Study of Peanut Allergy 2Health News:More and More American Women Go for Facelifts to Get Jobs 2Health News:One Third of US Troops Suffer from Mental Health Problems 2Health News:One Third of US Troops Suffer from Mental Health Problems 3Health News:Ontario Grants Fast-Track Compensation Rights for Work-Related Illnesses 2Health News:Ontario Grants Fast-Track Compensation Rights for Work-Related Illnesses 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: